FBLN5 and breast carcinoma: Yong-Hun et al. [29] found that FBLN5 initiated EMT through a matrix metalloproteinase-dependent mechanism and enhanced the extent of EMT induced by TGF-β-induced breast epithelial cells, suggesting that FBLN5 had tumor-promoting functions in breast cancer.